C. Galisteo

430 total citations
20 papers, 177 citations indexed

About

C. Galisteo is a scholar working on Rheumatology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, C. Galisteo has authored 20 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 3 papers in Pharmacology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in C. Galisteo's work include Osteoarthritis Treatment and Mechanisms (5 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). C. Galisteo is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (5 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). C. Galisteo collaborates with scholars based in Spain. C. Galisteo's co-authors include M. Larrosa, Jordi Gratacós, C. Orellana, E. Casado, Joan Calvet, Juan Pedro‐Botet, Mireia Moreno, Juan J. Chillarón, Marta Arévalo and Assumpta Caixàs and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

C. Galisteo

18 papers receiving 166 citations

Peers

C. Galisteo
José Roberto Provenza Brazil
Serap Özgül Türkiye
Atalay Doğru Türkiye
Barbara Shorter United States
Charles W. Butrick United States
Camilla Fongen Norway
Suvajit Samanta United States
Montserrat Romera Baurés Spain
Raffaele Felice Italy
G. Cassisi Italy
José Roberto Provenza Brazil
C. Galisteo
Citations per year, relative to C. Galisteo C. Galisteo (= 1×) peers José Roberto Provenza

Countries citing papers authored by C. Galisteo

Since Specialization
Citations

This map shows the geographic impact of C. Galisteo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Galisteo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Galisteo more than expected).

Fields of papers citing papers by C. Galisteo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Galisteo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Galisteo. The network helps show where C. Galisteo may publish in the future.

Co-authorship network of co-authors of C. Galisteo

This figure shows the co-authorship network connecting the top 25 collaborators of C. Galisteo. A scholar is included among the top collaborators of C. Galisteo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Galisteo. C. Galisteo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Narváez, Javier, Lydia Abásolo, J. Loricera, et al.. (2024). Sustained drug-free remission in giant cell arteritis. Lara D. Veeken. 64(5). 2919–2927. 1 indexed citations
3.
Calvet, Joan, Antonio Berenguer, C. Orellana, et al.. (2024). Specific-cytokine associations with outcomes in knee osteoarthritis subgroups: breaking down disease heterogeneity with phenotyping. Arthritis Research & Therapy. 26(1). 19–19. 7 indexed citations
4.
Calvet, Joan, Antonio Berenguer, Edwards Pradenas, et al.. (2022). Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients. Scientific Reports. 12(1). 14772–14772. 12 indexed citations
5.
Sánchez-Martín, Julio, J. Loricera, E. De Miguel, et al.. (2022). AB1366 ULTRASOUND ASSESSMENT OF THE EFFECTIVENESS OF TOCILIZUMAB IN GIANT CELL ARTERITIS. STUDY OF 26 PATIENTS FROM CLINICAL PRACTICE. Annals of the Rheumatic Diseases. 81. 1788–1789. 1 indexed citations
6.
Riancho‐Zarrabeitia, Leyre, Víctor M. Martínez-Taboada, Íñigo Rúa‐Figueroa, et al.. (2019). 86 Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?. Abstracts. 39(3). A62–A63. 4 indexed citations
7.
Calvet, Joan, et al.. (2018). Synovial calprotectin is a useful marker of inflammation in knee osteoarthritis. Osteoarthritis and Cartilage. 26. S182–S183.
8.
9.
Calvet, Joan, et al.. (2018). AB0963 Calprotectin as a useful marker of inflammation in knee osteoarthritis. Annals of the Rheumatic Diseases. 77. 1605–1606. 1 indexed citations
10.
Orellana, C., et al.. (2018). AB0962 Irisin levels are associated with exercise, pain and function in patients with knee osteoarthritis. Annals of the Rheumatic Diseases. 77. 1605–1605. 2 indexed citations
11.
Galisteo, C., Joan Calvet, C. Orellana, et al.. (2016). AB0437 Complications of The Minimally Invasive Biopsy of The Minor Salivary Gland. Annals of the Rheumatic Diseases. 75. 1056–1057. 3 indexed citations
12.
Orellana, C., et al.. (2015). AB0845 Monographic Consultation of Patients with Knee Osteoarthritis with Joint Effusion: Specific Care Model. Experience After one Year. Annals of the Rheumatic Diseases. 74. 1183–1183. 2 indexed citations
13.
Calvet, Joan, C. Orellana, M. Larrosa, et al.. (2015). High prevalence of cardiovascular co-morbidities in patients with symptomatic knee or hand osteoarthritis. Scandinavian Journal of Rheumatology. 45(1). 41–44. 38 indexed citations
14.
Castro, M. Fernández, José Luís Andreu, V. Martínez Taboada, et al.. (2015). AB0597 Sjogrenser Cohort: Clinical and Epidemiological Features of Primary SjÖgren's Syndrome in Spanish Rheumathology Departments. Annals of the Rheumatic Diseases. 74. 1099–1099. 1 indexed citations
15.
Orellana, C., et al.. (2011). 306 ASSOCIATION BETWEEN METABOLIC SYNDROME AND SYNOVITIS IN PATIENTS WITH KNEE OSTEOARTHRITIS. Osteoarthritis and Cartilage. 19. S142–S142. 2 indexed citations
16.
Orellana, C., Jordi Gratacós, C. Galisteo, & M. Larrosa. (2009). Sexual dysfunction in patients with fibromyalgia. Current Rheumatology Reports. 11(6). 437–442. 18 indexed citations
17.
Orellana, C., et al.. (2009). Sexual dysfunction in fibromyalgia patients.. PubMed. 26(4). 663–6. 51 indexed citations
18.
Moreno, Mireia, Jordi Gratacós, E. Casado, et al.. (2007). Utilidad del pamidronato en el tratamiento de la artropatía de Charcot. Reumatología Clínica. 3(6). 257–261. 11 indexed citations
19.
Moreno, Mireia, Jordi Gratacós, E. Casado, et al.. (2007). Usefulness of Pamidronate in the Treatment of Charcot's Arthropathy. Reumatología Clínica (English Edition). 3(6). 257–261. 5 indexed citations
20.
Larrosa, M., E. Casado, Antonio Gómez, et al.. (2007). Colecalciferol o calcidiol ¿qué metabolito utilizar en el déficit de vitamina D?. 16(3). 48–52. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Roberto Provenza Breakdown of academic impact, for papers by Serap Özgül Breakdown of academic impact, for papers by Atalay Doğru Breakdown of academic impact, for papers by Barbara Shorter Breakdown of academic impact, for papers by Charles W. Butrick Breakdown of academic impact, for papers by Camilla Fongen Breakdown of academic impact, for papers by Suvajit Samanta Breakdown of academic impact, for papers by Montserrat Romera Baurés Breakdown of academic impact, for papers by Raffaele Felice Breakdown of academic impact, for papers by G. Cassisi
Rankless by CCL
2026